BioSpace News Archive

CalciMedica Inc., a clinical-stage biotechnology company targeting calcium release-activated calcium channels for the treatment of acute and severe inflammatory diseases including acute viral pneumonia in COVID-19 patients, announced the appointment of Robert N. Wilson, a former vice chairman of the Johnson & Johnson board, to the Company’s board of directors as co-chairman with current board chairman, Robert McNeil, Ph.D.

Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that it will now host the Company’s 2020 Annual Meeting of Stockholders (the “Annual Meeting”) virtually due to the public health impact of the coronavirus (COVID-19) pandemic and to prioritize the health and well-being of meeting participants. As previously an

Representing a new era in digital radiography, Konica Minolta Healthcare Americas, Inc., announces the commercial availability of the KDR ® Advanced U-Arm, incorporating the award winning Dynamic Digital Radiography (DDR) capability. The KDR U-Arm with DDR recently received FDA clearance. DDR, or X-ray that Moves, provides a series of individual digital images acquired at high speed and low dose. The resulting cine loop presents a diagnostic-qual

Appointment of seasoned women’s health marketing executive is a key step in the transition to a fully-integrated drug development and commercial company with initial focus on vaginal yeast infection

BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, today announced that two Company abstracts were accepted at this year’s American Society of Clinical Oncology (ASCO) Virtual Scientific Program. Both abstracts evaluate BeyondSpring’s lead late-stage asset, Plinabulin, alongside Neulasta (pegfilgrastim), a long-lasting G-

ico metrix , the world leader to extract clinically meaningful data from brain scans, is proud to have launched the ico mpanion platform and phone application for people with multiple sclerosis on World MS Day! ico mpanion is a medical device and is currently available in English, French, German, and Dutch.

Simplify complex study logistics with GMP-compliant cryopreserved leukopak for the development and commercialization of cell and gene therapies

CEO Steven Klosk to Retire, President Shawn Cavanagh to Become Strategic Advisor to the Company Cambrex in Advanced Stages of Search for CEO Successor EAST RUTHERFORD, N.J.--( BUSINESS WIRE )-- Cambrex, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced that Steven Klosk will retire as Chief Executive Officer and member of the Board of Directors on

Asana BioSciences announced today positive topline results from a Phase 2b study evaluating the efficacy and safety of its investigational oral Janus kinase family (JAK) and spleen tyrosine kinase (SYK) inhibitor gusacitinib (ASN002) in 97 adult patients with moderate-to-severe chronic hand eczema (CHE). The study was a randomized, double-blind, placebo-controlled, parallel-group study evaluating oral gusacitinib (40

BIOMODEX, a pioneering digital health company that offers a unique and enhanced 3D printed solution for patient-specific rehearsal and physician training, today announced that Karl Schweitzer has been elected Chair of the Board of Directors, effective immediately.